Fatty degeneration of liver or treatment is used individually with adipohepatic composition, treatment method and the diagnostic method of infection with hepatitis C virus with what
The invention discloses a variety of pharmaceutical compositions and treatment methods, inhibited with what, eliminate or prevent a series of metabolic syndrome clinical manifestations, including diabetes B, hyperlipidemia, weight gain, obesity, insulin resistance, hypertension, atherosclerosis, fatty liver and certain chronic inflammation symptoms for leading to these clinical manifestations etc.. In in a further aspect, the present invention relates to numerous compositions and method, a possibility that its available what treatment, inhibition or reduction hepatites virus infections, including hepatitis B and infection with hepatitis C virus, and secondary disease state usually related with such virus infection and/or situation, including fatty degeneration of liver (steatohepatitis), cirrhosis, fatty liver and hepatocellular carcinoma and other diseases state or situation.本發明公開了多種藥物組合物和治療方法，用於抑制、消除或預防一系列代謝綜合征臨床表現，包括2型糖尿病、高脂血症、體重增加、肥胖症、胰島素抗性、高血壓、動脉粥樣硬化、脂肪肝和某些導致這些臨床表現的慢性炎症症狀等。在另外的方面中，本發明涉及多種組合物和方法，其可用於治療、抑制或降低肝炎病毒感染的可能性，包括乙型肝炎和丙型肝炎病毒感染，以及通常與這樣的病毒感染有關的繼發性疾病狀態和／或狀况，包括肝脂肪變性（脂肪性肝炎）、肝硬化、脂肪肝和肝細胞癌，以及其他疾病狀態或狀况。
